SUMMARY
This article will briefly summarize the key data presented at ASH 2017 related to hemostasis. In total, seven abstracts will be discussed.
(BELG J HEMATOL 2018;9(1):19–21)
By: H. Haguet , J. Douxfils PhD, PharmD, F. Mullier PhD, PharmD, J.M. Dogné
This article will briefly summarize the key data presented at ASH 2017 related to hemostasis. In total, seven abstracts will be discussed.
(BELG J HEMATOL 2018;9(1):19–21)
* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Hematology in Belgium and Luxembourg with prescription authorisation)
** (for healthcare professionals with prescribing authorisation working outside the field of Hematology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Hematology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)
Top
